2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline: structure & RN given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 122265 |
| CHEMBL ID | 1191534 |
| SCHEMBL ID | 2640021 |
| MeSH ID | M0153560 |
| Synonym |
|---|
| ici-169369 |
| gtpl273 |
| ici 169369 |
| PDSP1_001421 |
| PDSP2_001405 |
| 2-detpq |
| ethanamine, n,n-dimethyl-2-((3-phenyl-2-quinolinyl)thio)- |
| 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline |
| ici-169,369 |
| L001066 |
| n,n-dimethyl-2-(3-phenylquinolin-2-yl)sulfanylethanamine |
| CHEMBL1191534 |
| cas_122265 |
| bdbm84945 |
| nsc_122265 |
| ici 169,369 |
| ethanamine, n,n-dimethyl-2-[(3-phenyl-2-quinolinyl)thio]- |
| 4ct4cs5ba7 , |
| unii-4ct4cs5ba7 |
| 85273-95-6 |
| SCHEMBL2640021 |
| DTXSID40234468 |
| 2-(2-dimethylaminoethylthio)-3-phenylquinoline |
| AKOS030595293 |
| n,n-dimethyl-2-((3-phenyl-2-quinolinyl)thio)ethanamine |
| zm-169369 |
| ici-169369 free base |
| Q27078026 |
| n,n-dimethyl-2-((3-phenylquinolin-2-yl)thio)ethanamine |
| F87712 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1345170 | Human 5-HT6 receptor (5-Hydroxytryptamine receptors) | 1996 | Journal of neurochemistry, Jan, Volume: 66, Issue:1 | Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 10 (33.33) | 18.7374 |
| 1990's | 18 (60.00) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 4 (12.90%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 27 (87.10%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat. Neuroscience letters, Aug-08, Volume: 231, Issue: 2 | 1997 |
| Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat. Pharmacology, biochemistry, and behavior, Volume: 44, Issue: 4 | 1993 |
| Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity. The Journal of pharmacology and experimental therapeutics, Volume: 249, Issue: 3 | 1989 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients? British journal of clinical pharmacology, Volume: 27, Issue: 4 | 1989 |
| Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist. European journal of pharmacology, May-16, Volume: 180, Issue: 2-3 | 1990 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers. British journal of clinical pharmacology, Volume: 32, Issue: 4 | 1991 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |